Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
781 000 KRW
Market Closed
Updated:
May 15, 2024
Samsung Biologics Co Ltd
Total Other Income
|
Samsung Biologics Co Ltd
Total Other Income Peer Comparison
Comparables:
P
087010
K
278650
S
237690
F
220100
L
141080
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Total Other Income
₩3.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Total Other Income
₩1.8m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Total Other Income
₩636.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Total Other Income
₩163.8m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Total Other Income
₩218.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Total Other Income
₩339.1m
|
CAGR 3-Years
597%
|
CAGR 5-Years
57%
|
CAGR 10-Years
14%
|
See Also
What is Samsung Biologics Co Ltd's Total Other Income?
Total Other Income
3.6B
KRW
3.6B
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Total Other Income amounts to 3.6B KRW.
What is Samsung Biologics Co Ltd's Total Other Income growth rate?
Total Other Income CAGR 3Y
16%
16%
The average annual Total Other Income growth rates for Samsung Biologics Co Ltd have been 16% over the past three years .
You don't have any saved screeners yet
